| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/24/2011 | WO2011075516A3 Active scaffolds for on-demand drug and cell delivery |
| 11/24/2011 | WO2011068703A3 Methods of modulating inflammation in preterm infants using carotenoids |
| 11/24/2011 | WO2011058018A3 Biocompatible, magnetic nanoparticles for treating glioblastomae |
| 11/24/2011 | WO2011053792A4 Methods and compositions for sustained delivery of drugs |
| 11/24/2011 | WO2011050000A3 Single molecule nucleic acid nanoparticles |
| 11/24/2011 | WO2011039780A3 Topical formulation for diabetic foot ulcers |
| 11/24/2011 | WO2011036159A3 Treatment and prevention of hiv infection |
| 11/24/2011 | WO2011018185A3 Pharmaceutical tablet comprising rosuvastatin calcium |
| 11/24/2011 | WO2011006611A3 Pellets formulation |
| 11/24/2011 | WO2010144265A3 Ipamorelin diacetate injection and infusion solutions |
| 11/24/2011 | WO2010142400A3 Chitosan oligosaccharide-based compositions |
| 11/24/2011 | WO2010134047A3 Liquid dosage forms of isotretinoin |
| 11/24/2011 | WO2010118213A3 Particles for delivery of nucleic acids and related devices and methods |
| 11/24/2011 | WO2010107482A4 Germicidal composition |
| 11/24/2011 | WO2010052466A8 Pharmaceutical aerosol composition |
| 11/24/2011 | WO2010025435A3 Controlled-released peptide formulations |
| 11/24/2011 | WO2002030467A9 Pharmaceutical composition containing honey for the treatment of wounds |
| 11/24/2011 | US20110288651 Supercritical Carbon-Dioxide Processed Biodegradable Polymer Nanocomposites |
| 11/24/2011 | US20110288462 Haemostatic wound care article |
| 11/24/2011 | US20110288313 Process for modifying drug crystal formation |
| 11/24/2011 | US20110288238 Enhanced transport using membrane disruptive agents |
| 11/24/2011 | US20110288172 Dermatological compositions and methods |
| 11/24/2011 | US20110288135 Fast Dissolving Tablet |
| 11/24/2011 | US20110288124 Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 11/24/2011 | US20110288112 Method of Providing Sustained Analgesia With Buprenorphine |
| 11/24/2011 | US20110288099 Compositions with reduced hepatotoxicity |
| 11/24/2011 | US20110288056 Once daily formulations of tetracyclines |
| 11/24/2011 | US20110287168 Wet Granulation System Comprising at Least One Ultrasonic Nozzle |
| 11/24/2011 | US20110287166 Method and device for the continuous coating of cores by means of a dragee making apparatus |
| 11/24/2011 | US20110287104 Process for the production of an n-butyric acid compound in micro encapsulated form, for animal or human consumption |
| 11/24/2011 | US20110287103 Sustained-release formulations of topiramate |
| 11/24/2011 | US20110287102 Chain extenders |
| 11/24/2011 | US20110287101 Rapid release mini-tablets provide analgesia in laboratory animals |
| 11/24/2011 | US20110287100 Galenic Formulations of Organic Compounds |
| 11/24/2011 | US20110287099 Sustained-release formulations of topiramate |
| 11/24/2011 | US20110287098 Dissolution stability of calcium carbonate tablets |
| 11/24/2011 | US20110287097 Pharmaceutical compositions comprising ropinirole |
| 11/24/2011 | US20110287096 Modified gastroretentive drug delivery system for amine drugs |
| 11/24/2011 | US20110287095 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
| 11/24/2011 | US20110287094 Specific time-delayed burst profile delivery system |
| 11/24/2011 | US20110287093 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| 11/24/2011 | US20110287092 Compositions comprising decitabine and tetrahydrouridine and uses thereof |
| 11/24/2011 | US20110287091 Chronotherapeutic pharmaceutical composition |
| 11/24/2011 | US20110287090 Compositions and Methods for Inhibiting Expression of a Mutant Gene |
| 11/24/2011 | US20110287089 Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation |
| 11/24/2011 | US20110287088 Modulation of olfml-3 mediated angiogenesis |
| 11/24/2011 | US20110287087 Modified cationic liposome adjuvans |
| 11/24/2011 | US20110287086 Regeneration of Pancreatic Islets and Reversal of Diabetes by Islet Transcription Factor Genes Delivered in Vivo |
| 11/24/2011 | US20110287085 Liposomal curcumin for treatment of cancer |
| 11/24/2011 | US20110287084 Method for reducing body fat and increasing lean body mass by reducing stearoyl-coa desaturase 1 activity |
| 11/24/2011 | US20110287082 Multilayer Scaffold |
| 11/24/2011 | US20110287081 Bolus |
| 11/24/2011 | US20110287080 Coating ii |
| 11/24/2011 | US20110287079 Supporting material for cell sheet |
| 11/24/2011 | US20110287078 Novel porous biomaterials |
| 11/24/2011 | US20110287075 Electricity-generating particulates and the use thereof |
| 11/24/2011 | US20110287074 Antimicrobial Compositions, Methods of Manufacture Thereof and Articles Comprising the Same |
| 11/24/2011 | US20110287073 Emulsion Concentrate |
| 11/24/2011 | US20110287072 Prebiotic formulations and methods of use |
| 11/24/2011 | US20110287071 Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs |
| 11/24/2011 | US20110287070 Bone repair material and method for producing the same |
| 11/24/2011 | US20110287069 Solid oral formulations of a pyridopyrimidinone |
| 11/24/2011 | US20110287068 Fibrin and fibrinogen matrices and uses of same |
| 11/24/2011 | US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof |
| 11/24/2011 | US20110287066 Nanoporous Foamed Active Compound-Containing Preparations Based On Pharmaceutically Acceptable Thermoplastically Workable Polymers |
| 11/24/2011 | US20110287065 Nanoparticulate cinacalcet compositions |
| 11/24/2011 | US20110287064 Antibiotic coating |
| 11/24/2011 | US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies |
| 11/24/2011 | US20110287062 Chewable Formulation Comprising Alginate, Bicarbonate And Carbonate |
| 11/24/2011 | US20110287061 Dietary composition and method for promoting healthy hair growth and melanogenesis |
| 11/24/2011 | US20110287060 Erythritol-based hard coatings |
| 11/24/2011 | US20110286941 Combination of two material compositions for an oral hygiene product |
| 11/24/2011 | US20110286940 Composition for the treatment of keratinous fibers comprising at least one fixing polymer and at least one compound of the ceramide type and methods for using the composition |
| 11/24/2011 | US20110286939 Osteogenic compositions containing a coloring agent |
| 11/24/2011 | US20110286937 Synthetic glycolipid-containing liposome |
| 11/24/2011 | US20110286935 Multi-Functional Nano-Device |
| 11/24/2011 | US20110286934 Membrane transduction peptides, polynucleotides, and methods |
| 11/24/2011 | US20110286926 Degradable hydrogel compositions and methods |
| 11/24/2011 | US20110286915 Nanocarriers for Drug Delivery |
| 11/24/2011 | US20110284081 Photovoltaic thin-film cell produced from metallic blend using high-temperature printing |
| 11/24/2011 | DE102010009475B4 Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates A method for producing a metered the ready preparation |
| 11/24/2011 | DE102008006791B4 Transdermales Therapeutisches System mit Harnstoff-Komponente und Verfahren zu dessen Herstellung Transdermal therapeutic system with urea component and method for its production |
| 11/24/2011 | CA2816928A1 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles |
| 11/24/2011 | CA2800094A1 Liquid nasal spray containing low-dose naltrexone |
| 11/24/2011 | CA2799942A1 Pharmaceutical composition containing solifenacin |
| 11/24/2011 | CA2799928A1 Topical formulation for a jak inhibitor |
| 11/24/2011 | CA2799820A1 Posology and administration of glucocorticoid based compositions |
| 11/24/2011 | CA2799666A1 Stable ready to use injectable paracetamol formulation |
| 11/24/2011 | CA2798084A1 Drug delivery devices for delivery of ocular therapeutic agents |
| 11/24/2011 | CA2792669A1 Long - acting formulations of insulins |
| 11/23/2011 | EP2388009A1 Dermatological composition containing avermictin nanocapsules, method for preparing the same and uses thereof |
| 11/23/2011 | EP2388008A1 Stable, preservative-free, aqueous formulation for the administration by aerosolization comprising tobramycin |
| 11/23/2011 | EP2388004A1 Salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine |
| 11/23/2011 | EP2387994A1 Drug delivery systems comprising weakly basic drugs and organic acids |
| 11/23/2011 | EP2387993A1 Orally disintegrating tablets of zolmitriptan and process for preparing the same |
| 11/23/2011 | EP2387992A1 Improvements relating to nanodispersions |
| 11/23/2011 | EP2387991A1 Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 11/23/2011 | EP2387990A1 Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies |
| 11/23/2011 | EP2387989A2 Long - acting formulations of insulins |
| 11/23/2011 | EP2387985A1 Process for producing o/w microemulsion preparation for external application |